ChemicalBook > CAS DataBase List > IPI-549

IPI-549

Product Name
IPI-549
CAS No.
1693758-51-8
Chemical Name
IPI-549
Synonyms
Eganelisib;IPI-549;CS-2414;IPI-549(IPI549);IPI549 (Eganelisib);Eganelisib (IPI-549);IPI-549; IPI 549; IPI549.;Eganelisib, 10 mM in DMSO;Eganelisib (IPI-549) ，S8330;IPI-549, 98%, a potent and selective PI3Kγ Inhibitor
CBNumber
CB13147769
Molecular Formula
C30H24N8O2
Formula Weight
528.56
MOL File
1693758-51-8.mol
More
Less

IPI-549 Property

Density 
1.37±0.1 g/cm3(Predicted)
storage temp. 
-20°C
solubility 
Soluble in DMSO (up to at least 25 mg/ml)
form 
solid
pka
10.81±0.46(Predicted)
color 
Pale yellow
Stability:
Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 1 month.
InChIKey
XUMALORDVCFWKV-IBGZPJMESA-N
SMILES
C12=C(C(N[C@H](C3=CC4=C(C(=O)N3C3=CC=CC=C3)C(C#CC3=CN(C)N=C3)=CC=C4)C)=O)C(N)=NN1C=CC=N2
CAS DataBase Reference
1693758-51-8
More
Less

Safety

HS Code 
2933998090
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

Cayman Chemical
Product number
26416
Product name
IPI-549
Packaging
5mg
Price
$120
Updated
2024/03/01
Cayman Chemical
Product number
26416
Product name
IPI-549
Packaging
25mg
Price
$384
Updated
2024/03/01
Cayman Chemical
Product number
26416
Product name
IPI-549
Packaging
1mg
Price
$36
Updated
2024/03/01
Cayman Chemical
Product number
26416
Product name
IPI-549
Packaging
10mg
Price
$223
Updated
2024/03/01
TRC
Product number
I739410
Product name
IPI549
Packaging
5mg
Price
$95
Updated
2021/12/16
More
Less

IPI-549 Chemical Properties,Usage,Production

Description

IPI-549 (1693758-51-8) is a potent and highly selective inhibitor of PI3K-γ in both biochemical (IC50?= 16 nM) and cellular (IC50?= 12.2 nM) assays.1?Macrophage PI3K-γ has been found to be a critical switch between immune stimulation and suppression.2?IPI-549 has been used to reshape tumor immune microenvironments and promote cytotoxic T-cell-mediated tumor regression. Resistance to immune checkpoint blockade in 4T1 and B16-GMCSF tumors was overcome when anti-PD-1 or anti-CTLA4 therapies were combined with PI3K-γ inhibition via IPI-549.3?IPI-549 mono-treatment also resulted in tumor growth inhibition in several cancer cell lines.3?IPI-549 has also been shown to modulate P-glycoprotein-mediated multidrug resistance.4

Uses

IPI-549 is a selective phosphoinositide-3-kinase (PI3Kγ) Inhibitor. PI3Kγ inhibitors can be used to develop potential treatment for inflammatory and autoimmune diseases.

in vivo

Eganelisib (IPI549) demonstrates favorable pharmacokinetic properties and robust inhibition of PI3K-γ mediated neutrophil migration. In vivo (mice, rats, dog, and monkeys), Eganelisib has excellent oral bioavailability, low clearance, and distributed into tissues with a mean volume of distribution of 1.2 L/kg. Overall, Eganelisib has a favorable pharmacokinetic profile to allow potent and selective inhibition of PI3K-γ in vivo. The t1/2 of IPI-549 for mouse, rat, dog and monkey is 3.2, 4.4, 6.7 and 4.3 h, respectively. Eganelisib significantly reduces neutrophil migration in a dose dependent manner in this model when administered orally at all of the tested doses[1].

IC 50

PI3Kγ: 16 nM (IC50); PI3Kα: 3.2 μM (IC50); PI3Kβ: 3.5 μM (IC50)

References

[1] CATHERINE A. EVANS*. Discovery of a Selective Phosphoinositide-3-Kinase (PI3K)-γ Inhibitor (IPI-549) as an Immuno-Oncology Clinical Candidate[J]. ACS Medicinal Chemistry Letters, 2016, 7 9: 862-867. DOI:10.1021/acsmedchemlett.6b00238
[2] MEGAN M. KANEDA. PI3Kγ is a molecular switch that controls immune suppression[J]. Nature, 2016, 539 7629: 437-442. DOI:10.1038/nature19834
[3] OLIVIER DE HENAU. Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells[J]. Nature, 2016, 539 7629: 443-447. DOI:10.1038/nature20554
[4] ALBERT A. DE VERA . Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivo[J]. Cancer letters, 2019, 442: Pages 91-103. DOI:10.1016/j.canlet.2018.10.020

IPI-549 Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

IPI-549 Suppliers

China 118 United States 11 Global 129
Shanghai YuanQi Biotechnology Co., Ltd.
Tel
+86-2332782371 +86-18120098618
Email
sales@adobechem.com
Country
China
ProdList
1250
Advantage
50
Twochem Co.Ltd.
Tel
021-58111628 15800915896
Fax
QQ 3285589261
Email
sales@twochem.com
Country
China
ProdList
1788
Advantage
58
WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
Tel
17702719238 18971495150;
Email
sales@sun-shinechem.com
Country
China
ProdList
1077
Advantage
64
Chembest Research Laboratories Limited
Tel
+86-21-20908456
Fax
021-58180499
Email
sales@BioChemBest.com
Country
China
ProdList
6003
Advantage
61
Nanjing Chemlin Chemical Co., Ltd
Tel
025-83697070
Fax
+86-25-83453306
Email
info@chemlin.com.cn
Country
China
ProdList
15883
Advantage
64
Shanghai Topbiochem Technology Co., Ltd
Tel
021-58170097
Email
info@topbiochem.com
Country
China
ProdList
9510
Advantage
58
Shanghai Jian Chao Chemical Technology Co., Ltd.
Tel
150-2103-5486 18017383231
Fax
qq：2817624287
Email
983544897@qq.com
Country
China
ProdList
9342
Advantage
55
ShangHai Caerulum Pharma Discovery Co., Ltd.
Tel
18149758185
Email
sales-cpd@caerulumpharma.com
Country
China
ProdList
3506
Advantage
58
DKMbiochem.Co. Ltd
Tel
15901859516
Fax
15901859516
Email
sales@DKMbiochem.com
Country
China
ProdList
344
Advantage
58
Finetech Industry Limited
Tel
027-87465837 19945049750
Fax
027-8777-2287
Email
sales@finetechnology-ind.com
Country
China
ProdList
9637
Advantage
58

1693758-51-8, IPI-549Related Search:

S-Trityl-L-cysteine ZM 336372 LFM-A13 CL 82198 HYDROCHLORIDE

  • IPI-549
  • (S)-2-amino-N-(1-(8-((1-methyl-1H-pyrazol-4-yl)ethynyl)-1-oxo-2-phenyl-1,2-dihydroisoquinolin-3-yl)ethyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide
  • IPI-549(IPI549)
  • IPI-549, 98%, a potent and selective PI3Kγ Inhibitor
  • CS-2414
  • IPI-549; IPI 549; IPI549.
  • Pyrazolo[1,5-a]pyrimidine-3-carboxamide, 2-amino-N-[(1S)-1-[1,2-dihydro-8-[2-(1-methyl-1H-pyrazol-4-yl)ethynyl]-1-oxo-2-phenyl-3-isoquinolinyl]ethyl]-
  • IPI549 (Eganelisib)
  • Eganelisib
  • Eganelisib (IPI-549)
  • 2-Amino-N-[(1S)-1-[1,2-dihydro-8-[2-(1-methyl-1H-pyrazol-4-yl)ethynyl]-1-oxo-2-phenyl-3-isoquinolinyl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide
  • Eganelisib, 10 mM in DMSO
  • (S)-2-Amino-N-[1-[8-[(1-methyl-4-pyrazolyl)ethynyl]-1-oxo-2-phenyl-1,2-dihydro-3-isoquinolinyl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide
  • Eganelisib (IPI-549) ，S8330
  • 2-Amino-N-[(1S)-1-[1,2-dihydro-8-[2-(1-methyl-1H-pyrazol-4-yl)ethynyl]-1-oxo-2-phenyl-isoquinolin-3-yl]-ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide
  • 1693758-51-8
  • API
  • APIs